Sep 16, 2020 7:05am EDT IMV CEO to Participate at the Vaccines Panel of the Sachs Associates 20th Annual Biotech in Europe Forum
Aug 05, 2020 7:05am EDT IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study
Aug 03, 2020 7:05am EDT IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020
Jun 30, 2020 5:05pm EDT IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus
